That soaring oil price hit equity markets across the board today and AIM was no exception, with the index reaching the bell thirteen and a half points lower, although significantly up from intraday lows.
- Ovoca Bio +32%
- Kore Potash +29%
- Kropz +26%
- Mysale Group -54%
- Diurnal -19%
Ovoca Bio [LON:OVB] added 32% on the day after a note published this morning detailing its business exposure to Russia. The share price was rattled a few weeks back but has now regained that lost ground. The stock is however relatively thinly traded and did close on a spread of some 27% tonight, so it’s difficult to read too much into this.
Kore Potash LON:KP2 also fared well, adding 29% by the bell. The stock did find a degree of speculative support a few days back, but this proved to be rather short lived, resulting in a retreat ahead of the weekend. Today’s renewed move does however push the shares close to levels not seen for a year, with significantly elevated trade levels also being seen.
A notable mention for Kropz LON:KRPZ where we saw speculative gains last week and a further 26% has been tacked on today. This morning the company announced news of a further equity draw down, which strengthens the position of the major shareholder. That’s arguably going to limit free float but could also serve to pave the way for a buy out.
Mysale Group LON:MYSL is back in focus, off some 54% on the day. The stock took a pummelling off the back of last month’s trading update and in a day of very thin trading stepped lower yet again, although this was backed off by a very wide spread.
Diurnal LON:DNL also struggled, slipping 19% by the bell. An update from the Scottish Medicines Consortium has a negative outcome on the ability for one of its drugs to be prescribed. This is set to directly impact the company’s sales forecasts for the UK as a wider number of healthcare commissioning groups take direction from the SMC. However roll outs across Europe should still leave the company on track for 100% sales growth for the year to 30th June.